Search
  • Search


Ireland: Tenders/Mater Misericordiae University Hospital Ltd/Supply of an automated MALDI-TOF mass spectrometry system (Exent®) for the identification, isotyping and quantification of monoclonal immunoglobulins
  1. Questions deadline

    Jan 13, 11:00 AMJanuary 13, 2026 11:00 AM
  2. Tender submission deadline

    Jan 20, 11:00 AMJanuary 20, 2026 11:00 AM
  3. Tender validity period

    Apr 20, 10:00 AMApril 20, 2026 10:00 AM
  4. Result notice published

    Oct 7, 11:22 AMOctober 7, 2026 11:22 AM

Brief

Supply of an automated MALDI-TOF mass spectrometry system (Exent®) for the identification, isotyping and quantification of monoclonal immunoglobulins

Procedure
Without prior noticeTwo stages
Agreement
Buying goods

Brief

Mater Misericordiae University Hospital Ltd intends to enter into an agreement with The Binding Site Group Limited for the supply of the Exent® system, an integrated automated platform based on matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS), for the identification, isotyping and quantification of monoclonal immunoglobulins in Dublin, with a final contract value of 300,000 €. This direct award is due to The Binding Site being the sole manufacturer and supplier of a fully automated, integrated MALDI-TOF mass spectrometry platform validated for routine clinical use in the identification, isotyping and quantification of monoclonal immunoglobulins, with the system and its associated reagents, consumables and software being proprietary and protected by intellectual property rights.

Laboratorie- og analyseutstyr

Result

TED
  • Number of tenders received
    0
  • Contract value
    €300,000

Custom Assessment Criteria

  • Get answers to your bid/no-bid criteria

    Set them up once and Cobrief answers them in every tender

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Mater Misericordiae University Hospital Ltd

From the notice

  • This is a VEAT notice to indicate that the Mater Misericordiae University Hospital (MMUH) intends to utilise EU public procurement Directive 2014/24/EU, Article 32.2(b), negotiated procedure without prior publication, on the following grounds: (ii) competition is absent for technical reasons; and/or (iii) the protection of exclusive rights, including intellectual property rights. This notice is to indicate that MMUH intends to contract with The Binding Site Group Limited ("The Binding Site") for the supply of the Exent® system, an integrated automated platform based on matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS), for the identification, isotyping and quantification of monoclonal immunoglobulins in the diagnosis and monitoring of multiple myeloma and related plasma cell disorders. The justification for this decision is that The Binding Site is the sole manufacturer and supplier of a fully automated, integrated MALDI-TOF mass spectrometry platform validated for routine clinical use in the identification, isotyping and quantification of monoclonal immunoglobulins. No other economic operator manufactures or supplies an equivalent automated, integrated solution offering this combination of capabilities for routine clinical diagnostic use. The system and its associated reagents, consumables and software are proprietary to The Binding Site and are protected by intellectual property rights, and are not available from any other source. The equipment is required for the accurate and timely diagnosis, isotyping and monitoring of multiple myeloma and other monoclonal gammopathies, supporting improved patient outcomes through earlier detection and more sensitive monitoring of treatment response than conventional electrophoresis-based methods. The contracting authority has conducted a market review and is not aware of any other manufacturer offering a fully automated, integrated MALDI-TOF platform providing equivalent clinical functionality. The contracting authority therefore considers that no reasonable alternative or substitute exists and that competition is absent for technical reasons and by reason of the protection of exclusive rights, including intellectual property rights. The direct award is necessary to secure this clinically essential diagnostic capability.

  • Contact

    spriest@mater.ie
  • Type
    Result · Prequalification
  • Location
    Dublin
  • Main code
    Measuring instruments
    38300000

Similar active competitions

  • St James's Hospital

    Laboratorie- og analyseutstyr

    Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

    St James's Hospital needs Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department in Dublin for a maximum total value of 375,000 EUR over 60 months. The reagents and consumables are required to continue providing legacy clonality testing using capillary electrophoresis, while the laboratory develops Next Generation Sequencing (NGS) based testing methodologies.

    Competition
    Nov 19, 2026(0 days)
    €375,000
  • St James's Hospital

    Laboratorie-, optisk- og presisjonsutstyr

    Invitation to Tender for the Provision of an Immunoassay and Allergy Analytical Platform for the St James’s Hospital Immunology Laboratory.

    St James’s Hospital needs an immunoassay and allergy analytical platform for its Immunology Laboratory under a 5-year contract, with a maximum total value of €9.625 million. The supply will support automated testing of a broad range of autoantibodies and allergens used to investigate autoimmune and allergic diseases and inform diagnosis, monitoring and treatment for adult and paediatric patients. Delivery is for the hospital’s laboratory in Dublin.

    Competition
    Dec 10, 2026(21 days)
    €9,625,000
  • Università degli Studi di Padova

    Laboratorieutstyr og analyseinstrumenter

    Verifica di unicità del fornitore per l’affidamento della fornitura di uno spettrometro di massa ibrido quadrupolo ad altissima risoluzione accoppiato ad un UHPLC a microflussi e autocampionatore.

    L’Università degli Studi di Padova intende affidare al Dipartimento di Scienze Chimiche la fornitura di uno spettrometro di massa ibrido quadrupolo ad altissima risoluzione, accoppiato a un UHPLC a microflussi e a un autocampionatore, per la caratterizzazione analitica di molecole nell’ambito della metabolomica. Gli operatori interessati possono contribuire alla verifica dell’unicità del fornitore, segnalando la disponibilità di soluzioni alternative idonee.

    Planning
    Nov 30, 2026(11 days)
    €365,200